<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nixon BR</submitter><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>PHS HHS</funding><pagination>19136-47</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3365946</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>287(23)</volume><pubmed_abstract>AMP-activated protein kinase (AMPK) is an energy-sensing enzyme central to the regulation of metabolic homeostasis. In the heart AMPK is activated during cardiac stress-induced ATP depletion and functions to stimulate metabolic pathways that restore the AMP/ATP balance. Recently it was demonstrated that AMPK phosphorylates cardiac troponin I (cTnI) at Ser-150 in vitro. We sought to determine if the metabolic regulatory kinase AMPK phosphorylates cTnI at Ser-150 in vivo to alter cardiac contractile function directly at the level of the myofilament. Rabbit cardiac myofibrils separated by two-dimensional isoelectric focusing subjected to a Western blot with a cTnI phosphorylation-specific antibody demonstrates that cTnI is endogenously phosphorylated at Ser-150 in the heart. Treatment of myofibrils with the AMPK holoenzyme increased cTnI Ser-150 phosphorylation within the constraints of the muscle lattice. Compared with controls, cardiac fiber bundles exchanged with troponin containing cTnI pseudo-phosphorylated at Ser-150 demonstrate increased sensitivity of calcium-dependent force development, blunting of both PKA-dependent calcium desensitization, and PKA-dependent increases in length dependent activation. Thus, in addition to the defined role of AMPK as a cardiac metabolic energy gauge, these data demonstrate AMPK Ser-150 phosphorylation of cTnI directly links the regulation of cardiac metabolic demand to myofilament contractile energetics. Furthermore, the blunting effect of cTnI Ser-150 phosphorylation cross-talk can uncouple the effects of myofilament PKA-dependent phosphorylation from β-adrenergic signaling as a novel thin filament contractile regulatory signaling mechanism.</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.</pubmed_title><pmcid>PMC3365946</pmcid><funding_grant_id>HL 062426</funding_grant_id><funding_grant_id>T32 007692</funding_grant_id><funding_grant_id>R01 HL022231</funding_grant_id><funding_grant_id>R01 HL091986</funding_grant_id><funding_grant_id>HL 091056</funding_grant_id><funding_grant_id>HL 091986</funding_grant_id><funding_grant_id>T32 NS077984</funding_grant_id><pubmed_authors>Davis JP</pubmed_authors><pubmed_authors>Solaro RJ</pubmed_authors><pubmed_authors>Brundage EA</pubmed_authors><pubmed_authors>Nixon BR</pubmed_authors><pubmed_authors>Little SC</pubmed_authors><pubmed_authors>Thawornkaiwong A</pubmed_authors><pubmed_authors>Jin J</pubmed_authors><pubmed_authors>Biesiadecki BJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.</name><description>AMP-activated protein kinase (AMPK) is an energy-sensing enzyme central to the regulation of metabolic homeostasis. In the heart AMPK is activated during cardiac stress-induced ATP depletion and functions to stimulate metabolic pathways that restore the AMP/ATP balance. Recently it was demonstrated that AMPK phosphorylates cardiac troponin I (cTnI) at Ser-150 in vitro. We sought to determine if the metabolic regulatory kinase AMPK phosphorylates cTnI at Ser-150 in vivo to alter cardiac contractile function directly at the level of the myofilament. Rabbit cardiac myofibrils separated by two-dimensional isoelectric focusing subjected to a Western blot with a cTnI phosphorylation-specific antibody demonstrates that cTnI is endogenously phosphorylated at Ser-150 in the heart. Treatment of myofibrils with the AMPK holoenzyme increased cTnI Ser-150 phosphorylation within the constraints of the muscle lattice. Compared with controls, cardiac fiber bundles exchanged with troponin containing cTnI pseudo-phosphorylated at Ser-150 demonstrate increased sensitivity of calcium-dependent force development, blunting of both PKA-dependent calcium desensitization, and PKA-dependent increases in length dependent activation. Thus, in addition to the defined role of AMPK as a cardiac metabolic energy gauge, these data demonstrate AMPK Ser-150 phosphorylation of cTnI directly links the regulation of cardiac metabolic demand to myofilament contractile energetics. Furthermore, the blunting effect of cTnI Ser-150 phosphorylation cross-talk can uncouple the effects of myofilament PKA-dependent phosphorylation from β-adrenergic signaling as a novel thin filament contractile regulatory signaling mechanism.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Jun</publication><modification>2024-10-16T03:27:16.392Z</modification><creation>2019-03-27T00:54:05Z</creation></dates><accession>S-EPMC3365946</accession><cross_references><pubmed>22493448</pubmed><doi>10.1074/jbc.m111.323048</doi><doi>10.1074/jbc.M111.323048</doi></cross_references></HashMap>